A Study on Predictors of Treatment Response to Sofosbuvir and Ledipasvir Therapy in Patients with genotype 1 Chronic Hepatitis C Virus Infectio
Not Applicable
- Conditions
- Patients with genotype 1 HCV infection
- Registration Number
- JPRN-UMIN000019011
- Lead Sponsor
- Department of Gastroenterology and Hepatology, Graduate School of Medicine, Hokkaido University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 260
Inclusion Criteria
Not provided
Exclusion Criteria
1 Patients with poorly controlled cardiac disease (myocardial infarction, cardiac failure, arrhythmia) 2 Patients with severe hepatic impairment 3 Patients with a history of hypersensitivity to HCV NS5B inhibitors or Ribavirin 4 Patients with a concurrent malignancy, including hepatocellular carcinoma, at the start of treatment 5 Patients deemed unsuitable for study entry by their treating physician 6 Patients with renal dysfunction 7 Patients who are unsuitable, in the opinion of the principal investigator, for this study due to any other reason
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method